Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_assertion description "[TZDs including pioglitazone, rosiglitazone and troglitazone, by activating PPAR-? have shown pleiotropic effects in reducing vascular risk factors and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_assertion evidence source_evidence_literature NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_assertion SIO_000772 25521362 NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_assertion wasDerivedFrom befree-2016 NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_assertion wasGeneratedBy ECO_0000203 NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1249175.RAJ3O4EKNzwWJoBB4oCk9f6VCdl5zXnw5VfPPg82VelB0130_provenance.